Lyfnua Patient profiles Patient profiles Help identify patients in your practice who may benefit from ▼LYFNUA® (gefapixant) […]
Lyfnua Dosing Dosing1 Renal impairment1 Insufficient data are available in patients with end-stage renal disease […]
Lyfnua Tolerability Tolerability ▼ LYFNUA® (gefapixant) is non-narcotic with a safety profile established in two 52-week […]
Lyfnua Efficacy Efficacy ▼ LYFNUA® (gefapixant) is proven to help reduce 24-hour cough frequency and improve cough-s […]
Lyfnua Treatment of chronic cough Treatment of chronic cough Patients with refractory chronic cough (RCC) often experience a lengthy i […]
